Insider Trading - NeuroBo Pharmaceuticals Inc. (NRBO)

Real time insider trading transaction history:

  1. Insiders must file a Form 4 covering their trades within two business days.
  2. Section 16 prohibits insiders from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period:
Insider Trading Transactions for NeuroBo Pharmaceuticals Inc.
Goto 0, 1, Next

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2017-03-10
Purchase
2017-03-14
5:57 pm
Gemphire Therapeutics Inc. GEMP LICHTINGER PEDRO
Director
10,559 $9.47 $99,994 67,753
(Direct)
View
2017-03-10
Purchase
2017-03-14
6:07 pm
Gemphire Therapeutics Inc. GEMP SASSINE ANDY
Director
21,119 $9.47 $199,997 152,104
(Direct)
View
2018-02-08
Purchase
2018-02-12
4:31 pm
Gemphire Therapeutics Inc. GEMP Gullans Steven R. Ph.D.
CEO
71,429 $7 $500,003 930,252
(Indirect)
View
2018-02-08
Purchase
2018-02-12
4:40 pm
Gemphire Therapeutics Inc. GEMP Reno Seth
Chief Commercial Officer
14,286 $7 $100,002 18,286
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2017-03-28
Option Award
2017-03-29
4:17 pm
N/A
2027-03-27
Gemphire Therapeutics Inc. GEMP Golden Lee Scott
Chief Medical Officer
20,000 $0 20,000
(Direct)
View
2017-05-30
Option Award
2017-05-31
4:25 pm
N/A
2027-05-29
Gemphire Therapeutics Inc. GEMP Gullans Steven R. Ph.D.
CEO
60,000 $0 60,000
(Direct)
View
2017-07-31
Exercise
2017-08-02
4:11 pm
N/A
N/A
Gemphire Therapeutics Inc. GEMP Bisgaier Charles PhD
Chairman
Chief Scientific Off. & Chair
10% Owner
4,474 $1.344 1,350,362
(Direct)
View
2017-07-31
Exercise
2017-08-02
4:11 pm
2015-06-29
2025-06-28
Gemphire Therapeutics Inc. GEMP Bisgaier Charles PhD
Chairman
Chief Scientific Off. & Chair
10% Owner
4,474 $0 1,350,362
(Direct)
View
2017-08-10
Exercise
2017-08-11
4:07 pm
N/A
N/A
Gemphire Therapeutics Inc. GEMP MATHIESEN JEFFREY S
CFO
3,000 $3.59 10,927
(Direct)
View
2017-08-10
Exercise
2017-08-11
4:07 pm
2015-09-25
2025-09-24
Gemphire Therapeutics Inc. GEMP MATHIESEN JEFFREY S
CFO
3,000 $0 10,927
(Direct)
View
2017-08-10(A)
Exercise
2017-08-15
4:22 pm
N/A
N/A
Gemphire Therapeutics Inc. GEMP MATHIESEN JEFFREY S
CFO
3,000 $3.59 56,020
(Direct)
View
2017-08-10(A)
Exercise
2017-08-15
4:22 pm
2015-09-25
2025-09-24
Gemphire Therapeutics Inc. GEMP MATHIESEN JEFFREY S
CFO
3,000 $0 56,020
(Direct)
View
2017-08-14
Exercise
2017-08-16
4:10 pm
N/A
N/A
Gemphire Therapeutics Inc. GEMP MATHIESEN JEFFREY S
CFO
3,207 $3.59 14,134
(Direct)
View
2017-08-14
Exercise
2017-08-16
4:10 pm
2015-09-25
2025-09-24
Gemphire Therapeutics Inc. GEMP MATHIESEN JEFFREY S
CFO
3,207 $0 14,134
(Direct)
View
2018-01-29
Option Award
2018-01-30
4:06 pm
N/A
2028-01-28
Gemphire Therapeutics Inc. GEMP Gullans Steven R. Ph.D.
CEO
60,000 $0 60,000
(Direct)
View
2018-01-28
Option Award
2018-01-30
4:13 pm
N/A
2028-01-27
Gemphire Therapeutics Inc. GEMP Reno Seth
Chief Commercial Officer
48,000 $0 48,000
(Direct)
View
2018-01-28
Option Award
2018-01-30
4:20 pm
N/A
2028-01-27
Gemphire Therapeutics Inc. GEMP MATHIESEN JEFFREY S
CFO
48,000 $0 48,000
(Direct)
View
2018-01-28
Option Award
2018-01-30
4:27 pm
N/A
2028-01-27
Gemphire Therapeutics Inc. GEMP Golden Lee Scott
Chief Medical Officer
148,000 $0 148,000
(Direct)
View
2018-01-28
Option Award
2018-01-30
4:36 pm
N/A
2028-01-27
Gemphire Therapeutics Inc. GEMP Bisgaier Charles PhD
Chairman
Chief Scien Officer & Chair
10% Owner
48,000 $0 48,000
(Direct)
View
2018-01-29
Option Award
2018-01-30
4:44 pm
N/A
2028-01-28
Gemphire Therapeutics Inc. GEMP Hawryluk P. Kent
Director
10,800 $0 10,800
(Direct)
View
2018-01-29
Option Award
2018-01-30
4:52 pm
N/A
2028-01-28
Gemphire Therapeutics Inc. GEMP KOUSKY KENNETH W
Director
10,800 $0 10,800
(Direct)
View
2018-01-29
Option Award
2018-01-30
5:04 pm
N/A
2028-01-28
Gemphire Therapeutics Inc. GEMP LICHTINGER PEDRO
Director
10,800 $0 10,800
(Direct)
View
2018-01-29
Option Award
2018-01-30
5:12 pm
N/A
2028-01-28
Gemphire Therapeutics Inc. GEMP SASSINE ANDY
Director
10,800 $0 10,800
(Direct)
View
2018-05-01
Option Award
2018-05-03
4:32 pm
N/A
2028-04-30
Gemphire Therapeutics Inc. GEMP Gullans Steven R. Ph.D.
CEO
150,000 $0 150,000
(Direct)
View
2018-05-22
Option Award
2018-05-24
4:31 pm
N/A
2028-04-30
Gemphire Therapeutics Inc. GEMP Gullans Steven R. Ph.D.
CEO
100,000 $0 100,000
(Direct)
View
2019-07-24
Option Award
2019-07-26
4:01 pm
N/A
N/A
Gemphire Therapeutics Inc. GEMP Gullans Steven R. Ph.D.
CEO
300,000 $0 300,000
(Direct)
View
2019-07-24
Option Award
2019-07-26
4:10 pm
N/A
N/A
Gemphire Therapeutics Inc. GEMP Bisgaier Charles PhD
Chairman
Chief Scientific Off. & Chair
10% Owner
100,000 $0 1,450,362
(Direct)
View
2019-07-24
Option Award
2019-07-26
4:16 pm
N/A
N/A
Gemphire Therapeutics Inc. GEMP Reno Seth
Chief Commercial Officer
100,000 $0 118,286
(Direct)
View
2019-07-24
Option Award
2019-07-26
4:24 pm
N/A
N/A
Gemphire Therapeutics Inc. GEMP KOUSKY KENNETH W
Director
15,000 $0 26,935
(Direct)
View
2019-07-24
Option Award
2019-07-26
4:30 pm
N/A
N/A
Gemphire Therapeutics Inc. GEMP LICHTINGER PEDRO
Director
15,000 $0 74,833
(Direct)
View
2019-07-24
Option Award
2019-07-26
4:38 pm
N/A
N/A
Gemphire Therapeutics Inc. GEMP SASSINE ANDY
Director
15,000 $0 151,264
(Direct)
View
2019-12-30
Option Award
2020-01-02
9:52 pm
N/A
N/A
NeuroBo Pharmaceuticals Inc. NRBO Kim Na Yeon
Director
10% Owner
7,321,789 $0 1,864,799
(Indirect)
View
2019-12-30
Option Award
2020-01-02
9:53 pm
N/A
N/A
NeuroBo Pharmaceuticals Inc. NRBO Oh Jeong Gyun
Director
10% Owner
2,057,893 $0 240,051
(Indirect)
View
2019-12-30
Option Award
2020-01-02
9:54 pm
N/A
2029-01-28
NeuroBo Pharmaceuticals Inc. NRBO Versavel Mark
Chief Medical Officer
342,930 $0 342,930
(Direct)
View
2020-01-13
Option Award
2020-01-15
7:10 pm
N/A
2030-01-12
NeuroBo Pharmaceuticals Inc. NRBO GROVES JASON L
Director
60,000 $0 60,000
(Direct)
View
2020-01-13
Option Award
2020-01-15
7:11 pm
N/A
2030-01-12
NeuroBo Pharmaceuticals Inc. NRBO Gullans Steven R. Ph.D.
Director
60,000 $0 60,000
(Direct)
View
2020-01-13
Option Award
2020-01-15
7:12 pm
N/A
2030-01-12
NeuroBo Pharmaceuticals Inc. NRBO Jeong Tae Heum
Director
60,000 $0 60,000
(Direct)
View
2020-01-13
Option Award
2020-01-15
7:13 pm
N/A
2030-01-12
NeuroBo Pharmaceuticals Inc. NRBO Kim Na Yeon
Director
10% Owner
60,000 $0 60,000
(Direct)
View
2020-01-13
Option Award
2020-01-15
7:15 pm
N/A
2030-01-12
NeuroBo Pharmaceuticals Inc. NRBO Oh Jeong Gyun
Director
10% Owner
60,000 $0 60,000
(Direct)
View
2020-01-13
Option Award
2020-01-15
7:16 pm
N/A
2030-01-12
NeuroBo Pharmaceuticals Inc. NRBO Salsbury Michael
Director
60,000 $0 60,000
(Direct)
View
2020-09-01
Option Award
2020-09-03
6:48 pm
N/A
2030-09-01
NeuroBo Pharmaceuticals Inc. NRBO Swirsky Douglas J
Director
60,000 $0 60,000
(Direct)
View
2020-12-31
Option Award
2021-01-05
4:09 pm
N/A
N/A
NeuroBo Pharmaceuticals Inc. NRBO Bakshi Akash
COO
884,072 $0 913,085
(Direct)
View
2021-09-02
Option Award
2021-09-03
11:43 am
N/A
2031-09-01
NeuroBo Pharmaceuticals Inc. NRBO KOVEN ANDREW I
Director
60,000 $0 60,000
(Direct)
View
2021-11-03
Option Award
2021-11-04
4:57 pm
N/A
2031-11-03
NeuroBo Pharmaceuticals Inc. NRBO Price Ben Gil
CEO
616,666 $0 616,666
(Direct)
View
(A) Indicate amendment filing.
Goto 0, 1, Next